Skip to content

Fenugreek Wraps in Osteoarthritis of the Knee

Randomised Controlled Trial on the Efficacy of Fenugreek Wraps in Symptomatic Primary Gonarthrosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03528824
Acronym
BoGon
Enrollment
81
Registered
2018-05-18
Start date
2018-06-01
Completion date
2020-09-01
Last updated
2021-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Knee

Brief summary

This randomised controlled trial aims to investigate the efficacy of fenugreek wraps in the treatment of primary symptomatic osteoarthritis of the knee. 81 patients will be randomised into one of 3 groups and apply fenugreek wraps or diclofenac gel daily for 4 weeks or receive only usual care. Efficacy will be measured using questionnaire on pain, disability,function, quality of life and pressure pain sensitivity.

Interventions

OTHERFenugreek wrap

Daily application of fenugreek wraps for 1/2-2 hours per day, 4 weeks application

Daily application of diclofenac gel, 4 weeks application

Sponsors

Universität Duisburg-Essen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* osteoarthritis of the knee, Kellgren Lawrence stadium 2-3 * at least 50% of days with complaints in past 3 months * initial pain intensity \>45mm on a 100mm visual analoge scale

Exclusion criteria

* systemic medication with corticoids or immunosuppressive drugs * systemic medication with chondroitinsulfate or glucosamine * secondary arthrosis * operation on the knee within the past 12 months * injection within 4 weeks (cortisone) or 6 months prior (hyaluronic acid) * severe comorbidities (tumor, psychiatric disorders etc.) * participation in other studies, regarding gonarthrosis * asthma * pregnancy, breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Pain intensity4 weekspain intensity measured on three 0-100mm visual analogous scales (actual, mean, worst pain)

Secondary

MeasureTime frameDescription
measure yourself medical outcome profile (MYMOP)4 weeksevaluation of symptoms and limitations
Quality of Life (SF-36)4 weekshealth related quality of life with the validated SF-36 questionnaire
self-efficacy (ASES-D)4 weeksself-efficacy with the arthritis specific self efficacy scale in German
physical function (30second chair test)4 weeksvalidated test to measure how often patients can stand up from a chair in 30 seconds)
knee function (WOMAC)4 weeksphysical everyday function using the validated WOMAC questionnaire
Pressure pain sensitivity4 weeksmeasured by an algometer at predefined areas
Adverse events Safety measure4 weekssafety measure
Adverse events12 weekssafety measure
Pain intensity12 weekspain intensity measured on a three 0-100mmvisual analogous scales (actual, mean, worst pain)
Course of Pain4 weeksmeasured by a diary including pain intensity on a visual analogue scale, medication

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026